Proof Diagnostics
Cambridge, United States · Founded 2020
- Headquarters
- Cambridge, Massachusetts
- Founded
- 2020
- Business Model
- B2B
- Website
- proofdx.com
About
Proof Diagnostics is a healthcare technology company developing a CRISPR-based molecular diagnostic platform for rapid, lab-quality point-of-care testing. Founded in May 2020 by CRISPR pioneers Feng Zhang, Omar Abudayyeh, and Jonathan Gootenberg alongside entrepreneur Sid Shenai (CEO), the company licensed the STOPCovid CRISPR chemistry from the Broad Institute and engineered a portable smart reader capable of delivering results in as little as 18 minutes. The company has raised 45M from ARCH Venture Partners, F-Prime Capital, and Madrona Venture Group, with research support from NIH RADx, DARPA, and the Gates Foundation.
Summary
Proof Diagnostics is a Biotech company based in Cambridge, United States, founded in 2020.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...